Tumour size in cancer of the cervix

Acta Oncologica

Volumn 37, Issue 7-8, 1998, Pages 729-734

  Lambin, Philippe ^a,b   Kramar, Andrew ^a   Haie Meder, Christine ^a   Castaigne, Danielle ^a   Scalliet, Pierre ^a   Bouzy, Jeanine ^a   Malaise, Edmond Philippe ^a   Gerbaulet, Alain ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM 137;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; BRACHYTHERAPY; CESIUM RADIOISOTOPES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIATION DOSAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0032412490     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418698430115     Document Type: Article

References (25)

1. 1. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib IIa cervical cancer. Lancet 1997; 350: 535-40.
2. 2. Perez CA, Marvin Camel H, Kao MS, Hederman MA. Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: final report. Gynecol Oncol 1987; 27: 129-40.
3. 3. Pilleron JP, Durand JC, Lenoble JC. Carcinoma of the uterine cervix stages I and II treated by radiation therapy and extensive surgery: 1000 cases. Cancer 1972; 29: 593-6.
4. 4. American Joint Committee on Cancer, Manual for Staging of Cancer. 3rd ed. Phildelphia: JB Lippincott, 1988: 151-3.
5. 5. Dargent D, Frobert JL, Beau GV. Factor (tumour volume) and T factor (FIGO classification) in the assessment of cervix cancer prognosis: the risk of lymph node spread. Gynecol Oncol 1985; 22: 15-22.
6. 6. Eifel PJ, Morris M, Oswald MJ, Wharton JT, Delclos L. Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases. Cancer 1990; 65: 2507-14.
7. 7. Kapp DS, Fischer D, Gutierrez E, Kohorn EI, Schwartz PE. Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariable analysis of the effect of age, stage, histology and blood counts on survival. Int J Radiat Oncol Biol Phys 1983; 9: 445-55.
8. 8. Lowrey GC, Mendenhall WM, Million RR. Stage IB or IIA B carcinoma of the intact uterine cervix treated with irradiation: a multivariate analysis. Int J Radiat Oncol Biol Phys 1992; 24: 205-10.
9. 9. Barillot I, Horiot JC, Pigneux J, et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys 1997; 38: 969-78.
10. 10. Bolger BS, Dabbas M, Lopes A, Monaghan JM. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma. Gynecol Oncol 1997; 65: 309-13.
11. 11. Dattoli MJ, Gretz HF III, Beller U, et al. Analysis of multiple prognostic factors in patients with stage IB cervical cancer: age as a major determinant. Int J Radiat Oncol Biol Phys 1989; 17: 41-7.
12. 12. Maddux HR, Varia MA, Spann CO, Fowler WC, Rosenman JG. Invasive carcinoma of the uterine cervix in women age 25 or less. Int J Radiat Oncol Biol Phys 1990; 19: 701-6.
13. 13. Lambin P, Gerbaulet A, Kramar A, et al. Phase II trial comparing two different dose rates in brachytherapy of cervix carcinoma. Report at two years. Int J Radiat Oncol Biol Phys 1993; 25: 399-403.
14. 14. Lambin P, Gerbaulet A, Kramar A, et al. Comparison of two different dose rates in gynecological brachytherapy. A prospective randomized trial. Analysis of early effects. Eur J Cancer 1994; 30: 312-20.
15. 15. Haie-Meder C, Kramar A, Lambin P, et al. Analysis of late effects of a randomized trial comparing two low dose rates in cervix cancer brachytherapy. Int J Radiat Oncol Biol Phys 1993; 27 (Suppl 1): 129.
16. 16. Pierquin B, Chassagne D, Wilson F. Modern Brachytherapy. New York: Masson Publisher, 1987.
17. 17. ICRU (International Commission on Radiation Units and Measurements) report no. 38: dose and volume specifications for reporting intracavitary therapy in gynecology. Report 38.7910. Bethesda, MD: Woodmont Ave. 20814. USA, March 1985.
18. 18. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
19. 19. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Part II: analysis and examples. Br J Cancer 1977; 35: 1-39.
20. 20. Alvarez RD, Soong SJ, Kinney WK, et al. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol 1989; 35: 130-5.
21. 21. Brenner DJ. Dose, volume and tumour contra predictions in radiotherapy. Int J Radiat Oncol Biol Phys 1993; 27: 171-9.
22. 22. Lartigau E, Le Ridant AM, Lambin P, et al. Oxygenation of head and neck tumours. Cancer 1993; 71: 2319-25.
23. 23. Young S, Hill RP. Effects of reoxygeneation on cells from hypoxic regions of solid tumours: anti-cancer drug sensitivity and metastatic potential. J Natl Cancer Inst 1990; 82: 371-80.
24. 24. Spanos WJ Jr, King A, Keeney E, Wagner R, Slater JM. Age as a prognostic factor in carcinoma of the cervix. Gynecol Oncol 1989; 35: 66-8.
25. 25. Gerbaulet AL, Kunkler IH, Ker GR, et al. Combined radiotherapy and surgery: local control and complications in early carcinoma of the uterine cervix the Villejuif experience, 1975 1974. Radiother Oncol 1992; 23: 66-73.